Vaccine exposes evasive colorectal cancer...
Immunotherapy has taken hold as an effective treatment for a variety of advanced cancers, but so far, colorectal cancer has stubbornly resisted.
However, research led by MD Anderson shows that resistance could be struck down. The recent international clinical trial helped expose a weak spot that leaves about 5% of colorectal tumors receptive to immune attack. (see the related story "5 years in, the Moon...
Immune helper cells appear to fuel pancreatic cancer...
Immune cells that rush to repair damage caused by inflammatory tissue are subverted to cancer-promoting allies by pancreas cells that...
Improving practice to eliminate high risk and prevent...
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ...
Assets and obstacles in the fight to prevent HPV-related cancers
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the...
Immunotherapy, liquid biopsy research among AACR highlights
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research’s annual meeting,...
Fidler honored for landmark findings on cancer metastasis
The American Association for Cancer Research (AACR) has selected Isaiah J. Fidler, D.V.M., Ph.D., professor of Cancer Biology, as...
Removing melanoma's cloak of immune invisibility
Melanoma cells are able to evade cancer immunotherapy by using a specific protein to hide from immune system T cells out to seek and...